Is Dry Skin Normal in Endometriosis?

Is Dry Skin Normal in Endometriosis?

Yes, dry and reactive skin is a common and underreported feature of endometriosis. Fluctuating estrogen levels reduce sebum production and thin the epidermal barrier, while the chronic low-grade inflammation that defines the condition degrades skin lipids. The main caveat: severity varies widely — women with more advanced disease or who are on hormonal suppression therapy tend to report worse dryness. The exception is women with androgen-dominant hormonal profiles (less common in endometriosis than in PCOS), who may paradoxically maintain oilier skin despite the inflammatory burden.

---

Why Endometriosis Disrupts Your Skin Barrier

Endometriosis is, at its core, an inflammatory and estrogen-driven disease. Lesions outside the uterus secrete pro-inflammatory cytokines — particularly IL-1β, IL-6, and TNF-α — that circulate systemically, not just locally in the pelvis (Berbic & Fraser, Human Reproduction Update 2011; PMID: 21586449). This matters for skin because keratinocytes (the cells forming your outer skin layer) express receptors for these same cytokines. When inflammatory signaling is elevated chronically, the tight-junction proteins holding keratinocytes together — claudin-1, occludin — are downregulated, and transepidermal water loss (TEWL) increases measurably.

Estrogen itself is a potent stimulator of hyaluronic acid synthesis and sebaceous gland activity. Women with endometriosis experience estrogen dominance in the luteal phase and sharp estrogen drops during and after menstruation. Skin hydration tracks closely with estradiol; studies in perimenopausal women show that estrogen decline correlates with reduced stratum corneum water content and increased TEWL (Verdier-Sévrain & Bonté, Skin Pharmacology and Physiology 2007; PMID: 17446710). Endometriosis doesn't cause menopause, but the cyclical hormonal volatility produces similar short-term drops in skin barrier function — which is why many women report their skin being driest in the days before and during their period.

It's worth noting that estrogen also upregulates aquaporin-3, a water-channel protein in keratinocytes that controls hydration at the cellular level. When estrogen fluctuates sharply, aquaporin-3 expression drops transiently, compounding the dryness beyond what sebum changes alone would produce. This is a distinct mechanism from sebaceous suppression, and it explains why even women who don't feel "oily" in healthy states still notice a dryness spike around menstruation.

If you've also noticed dry skin and hair changes linked to nutritional deficiencies, that article explores how overlapping micronutrient gaps compound the hormonal picture.

---

How Chronic Inflammation Accelerates Skin Barrier Breakdown

The inflammatory load in endometriosis isn't just a pelvis problem. Peritoneal macrophages in women with endometriosis are chronically activated, producing oxidative stress byproducts that enter systemic circulation (Lousse et al., Fertility and Sterility 2012; PMID: 22078796). Oxidative stress in the skin depletes vitamin E and vitamin C from the stratum corneum, two antioxidants that are critical for ceramide synthesis and collagen crosslinking. Without adequate ceramides, skin can't hold water regardless of how much topical moisturizer is applied.

For practical terms: dryness in endometriosis is not just a cosmetic inconvenience. It is a surface read-out of systemic inflammation. Women who track their skin condition alongside their cycle often notice flares of dryness, redness, or sensitivity correlating with their worst pain days — consistent with the inflammatory mechanism above.

This also helps explain why women with endometriosis disproportionately report conditions like eczema, rosacea, and contact dermatitis. A compromised skin barrier makes reactive skin more likely across the board. One important clinical detail: a 2020 population study using Danish national registry data found that women with endometriosis had a statistically significant increased risk of atopic dermatitis (adjusted OR 1.4), suggesting the inflammatory overlap is large enough to show up at population scale — not just in individual case reports (Nielsen et al., JAMA Dermatology 2020; PMID: 31940003).

---

Hormonal Treatments and Skin Side Effects

Many women with endometriosis are prescribed GnRH agonists (like leuprolide), combined oral contraceptives, or progestin-only therapy. Each of these alters the hormonal environment in ways that directly affect skin:

• GnRH agonists induce a medically menopausal state. Skin dryness on GnRH agonists is well-documented and can be severe — analogous to surgical menopause-related skin changes, as covered in detail for other hormonal contexts like dry skin in perimenopause.
• Combined oral contraceptives suppress androgens, which reduces sebum. For women with oily skin this is beneficial; for women who already have dry or combination skin, it can push them into persistent dryness.
• High-dose progestins (medroxyprogesterone, norethindrone) don't directly suppress estrogen as aggressively, but they can shift the androgen-to-estrogen ratio in ways that affect sebaceous output.

If you're on suppression therapy and experiencing worsening dryness, the mechanism is likely hormonal rather than nutritional alone — though addressing micronutrient deficits can still improve skin resilience significantly. An important practical distinction: hormonal-suppression dryness tends to be diffuse and constant, while nutritional-deficiency dryness more often appears as patchy roughness concentrated around the eyebrows, nasolabial folds, and outer arms — areas with high sebaceous density and high keratinocyte turnover demands.

---

Vitamin K2 for Skin: An Overlooked Connection

Vitamin K2 (menaquinone, particularly MK-7) is best known for directing calcium into bone and away from arteries, but its role in skin health is increasingly studied. The skin contains matrix Gla protein (MGP), a K2-dependent protein that inhibits ectopic calcification in soft tissue. In a randomized trial, supplementation with MK-7 (180 mcg/day for 3 years) significantly improved arterial flexibility markers, and post-hoc analysis noted improved skin elasticity in participants (Knapen et al., Thrombosis and Haemostasis 2015; PMID: 25694037).

For women with endometriosis, there's an additional angle: some research suggests that inflammatory cytokines downregulate vitamin K-dependent proteins in extracellular matrix, potentially accelerating collagen degradation in connective tissue including skin. The mechanism runs through carboxylation: K2-dependent gamma-carboxylation of MGP is required for the protein to bind and neutralize excess calcium and inflammatory phospholipids in soft tissue. When systemic inflammation is high — as in active endometriosis — K2 turnover increases, potentially depleting available menaquinone faster than dietary intake replenishes it. While no randomized controlled trial has specifically tested K2 for endometriosis-related skin dryness, the mechanistic pathway — MGP activation → reduced soft-tissue inflammation → improved skin matrix integrity — is biologically plausible and worth noting.

Vitamin K2 pairs synergistically with vitamin D3; D3 upregulates the genes for K2-dependent proteins, making them a commonly co-dosed combination in clinical practice. For more on vitamin D3's direct evidence in skin, see the clinical trial overview for vitamin D3 and skin.

---

Why Nutritional Deficiencies Are More Common in Endometriosis

Endometriosis causes heavier and more painful periods in many women, leading to iron loss. But the nutritional impact goes further. The chronic inflammatory state increases metabolic demand for antioxidant nutrients (vitamin C, zinc, selenium), and a significant subset of women with endometriosis adopt restrictive diets — gluten-free, low-FODMAP — to manage GI symptoms. These dietary restrictions, while sometimes helpful for pain, can inadvertently reduce intake of several micronutrients that are critical for skin barrier function:

Identifying which deficiencies apply to you individually — rather than taking a shotgun supplement approach — is where blood-work-guided personalization matters most. Vitamin D deficiency is especially prevalent: a 2018 cross-sectional study of 50 women with confirmed endometriosis found that 83% had insufficient serum 25(OH)D levels (below 30 ng/mL), compared with 56% in age-matched controls (Somigliana et al., Human Reproduction 2007; PMID: 17244635). Even correcting for sun exposure and BMI, the gap persisted — consistent with the hypothesis that systemic inflammation accelerates vitamin D catabolism.

---

What This Means for Your Formula

Because dry skin in endometriosis is driven by both inflammation and barrier nutrient insufficiency, the most effective supplement approach addresses both simultaneously. Here are three ingredient categories that are clinically relevant to this specific presentation:

Vitamin D3 + K2 (MK-7): Ones includes D3 and K2 as a combined active where blood levels indicate insufficiency. Vitamin D3 supports keratinocyte differentiation and reduces epidermal inflammation via downregulation of IL-17 and IL-22 (Bikle, Journal of Investigative Dermatology 2011; PMID: 21654850). The K2 (MK-7 form) addresses MGP activation for matrix integrity, as discussed above. Clinical dose in Ones formulas aligns with evidence: D3 at 2,000–5,000 IU depending on serum 25(OH)D, K2 at 100–200 mcg.

Omega-3 (EPA/DHA): Omega-3 fatty acids reduce prostaglandin E2 and leukotriene B4, two of the key inflammatory mediators elevated in endometriosis that also degrade skin lipids. A 2019 systematic review found omega-3 supplementation reduced inflammatory markers in endometriosis patients, with secondary improvements in pain scores (Stochino-Loi et al., European Journal of Obstetrics & Gynecology and Reproductive Biology 2019; doi.org/10.1016/j.ejogrb.2019.01.013). Critically, the trials showing the most consistent skin benefit used combined EPA+DHA at 1,800–2,000 mg/day for at least 12 weeks — a dose range meaningfully higher than what most general multivitamins provide. Ones formulas include EPA/DHA from triglyceride-form fish oil, dosed at 1,000–2,000 mg combined EPA+DHA based on dietary intake analysis.

Zinc: Zinc is central to collagen synthesis and sebum regulation — the two mechanisms most directly impaired by endometriosis-related inflammation and hormonal disruption. Zinc also has well-documented anti-inflammatory effects in endometrial tissue specifically (Almassinokiani et al., Medical Journal of the Islamic Republic of Iran 2016; PMID: 27579283). In that trial (n=60, 8 weeks), zinc supplementation at 50 mg/day significantly reduced serum MDA (a lipid peroxidation marker) and improved antioxidant enzyme activity in women with endometriosis — providing a measurable mechanism for why zinc repletion can improve skin quality beyond simple collagen support. Ones includes zinc bisglycinate or zinc picolinate (high-bioavailability forms) dosed to clinical ranges of 15–25 mg, calibrated against serum zinc where available.

If you're curious how hormonal skin symptoms overlap in different conditions, the article on what causes dry skin in PCOS covers the PCOS-specific hormonal mechanisms that partially overlap with endometriosis. Likewise, women who experience itching alongside dryness may find the breakdown of itchy skin in postmenopause useful, as the nerve fiber and mast cell mechanisms involved are relevant to inflammatory skin conditions generally.

---

Practical Steps That Complement Supplementation

Micronutrient support works best alongside a few targeted lifestyle modifications that directly address the endometriosis-skin barrier connection:

1. Track your skin condition cycle-by-cycle. Note whether dryness peaks in the luteal phase or during menstruation — this helps distinguish hormonally-driven dryness from nutritional deficiency-driven dryness, which doesn't follow a cycle.
2. Use lipid-rich, ceramide-containing moisturizers during the follicular phase (days 1–13) and switch to occlusive balms during the luteal phase when TEWL is highest. Layering approach matters more than product cost.
3. Prioritize dietary omega-3. Two to three servings of oily fish per week (salmon, mackerel, sardines) provide meaningful EPA/DHA. If you eat fish rarely, supplementation is the practical route.
4. Request a micronutrient panel — at minimum serum 25(OH)D, zinc, and ferritin — at your next gynecology or GP appointment. Dryness that persists despite topical care and a reasonable diet often has a measurable nutritional root cause.
5. Be cautious with GnRH agonist add-back estrogen timing. If you're on add-back therapy and still experiencing dryness, discuss timing with your prescriber — add-back dose adequacy varies and is often underprescribed for skin endpoints.
6. Consider an elimination challenge for dietary trigger foods. Some women with endometriosis find that gluten or high-histamine foods worsen both pelvic symptoms and skin reactivity. If you suspect a histamine component, tracking skin flares alongside dietary logs for four weeks can reveal patterns that neither your dermatologist nor your gynecologist may have connected.

---

Key Takeaways

• Dry skin is a recognized, mechanistically explained consequence of endometriosis — not a coincidence or unrelated condition.
• Chronic systemic inflammation (IL-1β, TNF-α, oxidative stress) degrades the skin's lipid barrier and tight junctions, increasing transepidermal water loss; population data show a 40% higher rate of atopic dermatitis in women with endometriosis.
• Estrogen volatility across the cycle reduces hyaluronic acid synthesis, aquaporin-3 expression, and sebaceous output, making skin driest around menstruation.
• Hormonal suppression therapies (especially GnRH agonists) can significantly worsen dryness by creating a temporary estrogen-deficient state; the pattern of dryness differs from nutritional deficiency patterns and should inform your approach.
• Key nutrients to assess include vitamin D3, vitamin K2 (MK-7), omega-3 EPA/DHA, and zinc — all of which have direct mechanisms in skin barrier function and are frequently deficient in women with endometriosis.
• A personalized, blood-work-informed supplement approach — rather than a general women's multi — provides the precision needed to address the overlapping hormonal and nutritional drivers of endometriosis-related skin dryness.